Abstract
Hypertension is a complex, multifactorial disorder which is an important cause of morbidity and mortality in the modern world. The study of hypertension in the context of the metabolic syndrome has yielded some important insights into the etiology of the condition. With the recent controversy surrounding the existence of the metabolic syndrome and the clear need for further research, we have undertaken a four part review of the literature in this field to provide a comprehensive overview of experimental and clinical research as it currently stands. In Part One, we review the history of hypertension and the metabolic syndrome, discuss the role of the metabolic syndrome as a concept and a diagnosis, and provide an introduction to insulin resistance and hyperinsulinemia. We also provide a broad overview of the range of animal models which are used to study these conditions.
Keywords: Metabolic syndrome, hypertension, obesity, insulin resistance, epidemiology, history, definition of metabolic syndrome, hyperinsulinemia, insulin sensitivity, Homeostasis Model Assessment
Current Vascular Pharmacology
Title: The Etiology of Hypertension in the Metabolic Syndrome Part One: An Introduction to the History, the Concept and the Models
Volume: 4 Issue: 4
Keywords: Metabolic syndrome, hypertension, obesity, insulin resistance, epidemiology, history, definition of metabolic syndrome, hyperinsulinemia, insulin sensitivity, Homeostasis Model Assessment
Abstract: Hypertension is a complex, multifactorial disorder which is an important cause of morbidity and mortality in the modern world. The study of hypertension in the context of the metabolic syndrome has yielded some important insights into the etiology of the condition. With the recent controversy surrounding the existence of the metabolic syndrome and the clear need for further research, we have undertaken a four part review of the literature in this field to provide a comprehensive overview of experimental and clinical research as it currently stands. In Part One, we review the history of hypertension and the metabolic syndrome, discuss the role of the metabolic syndrome as a concept and a diagnosis, and provide an introduction to insulin resistance and hyperinsulinemia. We also provide a broad overview of the range of animal models which are used to study these conditions.
Export Options
About this article
Cite this article as:
The Etiology of Hypertension in the Metabolic Syndrome Part One: An Introduction to the History, the Concept and the Models, Current Vascular Pharmacology 2006; 4 (4) . https://dx.doi.org/10.2174/157016106778521616
DOI https://dx.doi.org/10.2174/157016106778521616 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Basis of Inflammation and Insulin Resistance in Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Signal Transduction Therapy of Diabetic Vascular Complication
Current Signal Transduction Therapy Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
Current Pharmaceutical Biotechnology Patents in Diagnosis of Preeclampsia
Recent Patents on Biomarkers Clinical and Molecular Genetic Aspects of Hypertrophic Cardiomyopathy
Current Cardiology Reviews The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Current Pharmacogenomics and Personalized Medicine Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Current Cardiology Reviews Stress, Cardiovascular Diseases and Surgery-Induced Angiogenesis
Current Angiogenesis (Discontinued) Passive Smoking and Coronary Heart Disease
Current Vascular Pharmacology Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC)
Current Drug Targets Mediterranean Diet Rich in Olive Oil and Obesity, Metabolic Syndrome and Diabetes Mellitus
Current Pharmaceutical Design Knowledge about Medicine Use in Pregnancy: A National Study among Pharmacy Students in Jordan
Current Reviews in Clinical and Experimental Pharmacology Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)
Current Signal Transduction Therapy The Role of Trophoblast Nutrient and Ion Transporters in the Development of Pregnancy Complications and Adult Disease
Current Vascular Pharmacology Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke
Current Neurovascular Research Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism
Current Hypertension Reviews Plant Extracts and their Secondary Metabolites as Modulators of Kinases
Current Topics in Medicinal Chemistry Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis
Current Pharmaceutical Biotechnology